Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial–mesenchymal transition and PI3K alterations
Year: 2014
Type: article
Study design: Observational Study
Source: Gynecologic Oncology
Authors: E. Wik, J. Trovik, K. Kusonmano, E. Birkeland, M.B. Raeder, I. Pashtan, E.A. Hoivik, C. Krakstad, H.M.J. Werner, F. Holst, S. Mjøs, M.K. Halle, M. Mannelqvist, K.K. Mauland, A.M. Oyan, I.M. Stefansson, K. Petersen, R. Simon, A.D. Cherniack, M. Meyerson, K.H. Kalland, L.A. Akslen, H.B. Salvesen
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2030043768
